With the FDA expecting to approve 10–20 Cell and Gene Therapies (CGTs) annually by 2025, it is evident that the field will continue to hold immense commercial and medical opportunities. To harness ...
Gene therapy is reshaping modern medicine, offering the potential for lasting, even curative treatments for a wide range of ...
There is no margin for error in the pharma and biopharma sectors. If the chain-identity breaks anywhere along the way, there ...
This story is part of a series on the current progression in Regenerative Medicine. In 1999, I defined regenerative medicine as the collection of interventions that restore tissues and organs damaged ...
Forbes contributors publish independent expert analyses and insights. William A. Haseltine, Ph.D., covers genomics and regenerative medicine One of the more exciting opportunities in medical ...
INDIANAPOLIS – Elin Lewis, a 12-year-old from Greenwood, has made history as the first patient in the state to receive a ...
In this webinar, Gonçalo Regalo discusses how raw materials, media composition, and process design influence scalable cell ...
Beta thalassemia major, also known as Cooley’s anemia and transfusion-dependent beta thalassemia, causes the body’s red blood ...
A MeiraGTx Holdings gene therapy for Parkinson’s disease has preliminary data from a small clinical trial showing the one-time treatment showed both safety and efficacy, results that lay the ...
Morning Overview on MSN
A new gene-editing treatment just drove back advanced stomach and colon cancers in an early trial — by reprogramming patients’ own immune cells to hunt the tumors
Twelve people whose stomach or colon cancers had defeated every available treatment were infused with their own immune cells, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results